Estrogen Receptor Dependent Inhibitors of NF-κB Transcriptional Activation-1 Synthesis and Biological Evaluation of Substituted 2-Cyanopropanoic Acid Derivatives: Pathway Selective Inhibitors of NF-κB, a Potential Treatment for Rheumatoid Arthritis
摘要:
Pathway selective ligands of the estrogen receptor inhibit transcriptional activation of proinflammatory genes mediated by NF kappa B. Substituted 2-cyanopropanoic acid derivatives were developed leading to the discovery of WAY-204688, an orally active, pathway selective, estrogen receptor dependent anti-inflammatory agent. This propanamide was shown to be orally active in preclinical models of inflammatory diseases, such as rheumatoid arthritis, without the proliferative effect associated with traditional, estrogens.
[EN] INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE L'AMINOPEPTIDASE RÉGULÉE PAR L'INSULINE (IRAP) ET LEURS APPLICATIONS
申请人:HOWARD FLOREY INST
公开号:WO2009065169A1
公开(公告)日:2009-05-28
The present invention relates to inhibitors of insulin-regulated aminopeptidase (IRAP) and methods for inhibiting same, as well as compositions comprising said inhibitors. In particular, the inhibitors of the present invention may be useful in therapeutic applications including enhancing memory and learning functions.
INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF
申请人:CHAI SIEW YEEN
公开号:US20120309787A1
公开(公告)日:2012-12-06
The present invention relates to inhibitors of insulin-regulated aminopeptidase (IRAP) and methods for inhibiting same, as well as compositions comprising said inhibitors. In particular, the inhibitors of the present invention may be useful in therapeutic applications including enhancing memory and learning functions.
Estrogen Receptor Dependent Inhibitors of NF-κB Transcriptional Activation-1 Synthesis and Biological Evaluation of Substituted 2-Cyanopropanoic Acid Derivatives: Pathway Selective Inhibitors of NF-κB, a Potential Treatment for Rheumatoid Arthritis
作者:Thomas J. Caggiano、Antony Brazzale、Douglas M. Ho、Christina M. Kraml、Eugene Trybulski、Christopher C. Chadwick、Sue Chippari、Lisa Borges-Marcucci、Amy Eckert、James C. Keith、Thomas Kenney、Douglas C. Harnish
DOI:10.1021/jm701013k
日期:2007.11.1
Pathway selective ligands of the estrogen receptor inhibit transcriptional activation of proinflammatory genes mediated by NF kappa B. Substituted 2-cyanopropanoic acid derivatives were developed leading to the discovery of WAY-204688, an orally active, pathway selective, estrogen receptor dependent anti-inflammatory agent. This propanamide was shown to be orally active in preclinical models of inflammatory diseases, such as rheumatoid arthritis, without the proliferative effect associated with traditional, estrogens.
Mn-MOF@Pi composite: synthesis, characterisation and an efficient catalyst for the Knoevenagel condensation reaction
[email protected] composite by encapsulation of piperidine in desolvated Mn-MOF and investigated its catalytic performance in Knoevenagelcondensation reaction. The newly developed composite is compatible with various aromatic aldehydes and converting them to the desired Knoevenagelcondensation products in good yields and selectivity. Furthermore, composite [email protected] is reusable and shows good catalytic